Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Meningeal Neoplasms 1Medulloblastoma 1Hepatoblastoma 1

Interventions

Carboplatin 23Etoposide 19Vincristine 16Melphalan 13Filgrastim 13Topotecan 10Granulocyte Colony-Stimulating Factor 9Cyclophosphamide 8Thiotepa 7Cryotherapy 7Peripheral Blood Stem Cell Transplantation 4Mesna 4Drug Therapy 4Doxorubicin 3Busulfan 3Brachytherapy 3Temozolomide 2Radiotherapy 2Platinum Compounds 2Magnetic Resonance Imaging 2Ifosfamide 2Eye Enucleation 2Cisplatin 2Blood Specimen Collection 2trioctyl phosphine oxide 1sargramostim 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1omburtamab I-131 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Retinoblastoma × omburtamab I-131 × Clear all
NCT05064306 2025-08-01

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Memorial Sloan Kettering Cancer Center

No longer available
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Meningeal Neoplasms, Wilms Tumor, Neuroblastoma, Pinealoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡